Skip Navigation

Display Mode:

  • Choose Default Style
  • Choose High Contrast
PAMF Health Education | California Medical Information
  • Health Education Home
  • PAMF Home
  • About Us
  • Class Search
  • Lectures/Events
  • Support Groups
  • Health Resource Centers
  • Services
  • References
Section TitleReferences
  • Health Maintenance Guidelines
    • Ages 0-18
    • Ages 19-39
    • Ages 40-49
    • Ages 50-74
    • Ages 75+
    • Screening Tests
    • Health Maintenance Evaluation
    • Advance Health Care Directive
    • Additional Resources
    • Steps to Better Health
    • Definitions
    Main content

    Supplemental Pneumonia Vaccine Dose

    Pneumococcal Conjugate Vaccine
    13-valent (PCV-13)

    Infection with pneumococcal bacteria can cause fever, ear infections, meningitis and pneumonia. These conditions can make infants and young children very miserable, and in some cases can even be life threatening. That is why doctors have long recommended that children get four doses of the pneumococcal bacteria vaccine PCV7.

    This routine immunization schedule helps protect young children against seven strains or types of pneumococcal bacteria. Because doctors have vaccinated children with PCV7 since 2000, significantly fewer children now become ill from these seven strains.

    However, even though there is less disease overall, other strains of pneumococci that PCV7 does not protect against have become more common. As a result, children are now at increased risk from these other types of pneumococcal bacteria, including one type that can resist treatment with antibiotics.

    How can I protect my child?

    The manufacturers of the PCV7 vaccine have developed an updated version of their vaccine called PCV13 that protects against another six strains of pneumococcal bacteria. In particular, PCV13 vaccine protects against serotype 19A, which has become the most common type of pneumococcal bacteria and is often difficult to treat because it can sometimes resist antibiotics.

    The CDC's Advisory Committee on Immunization Practices recommends that children who have received PCV7 vaccine injections also get a "supplement" dose of the new PCV13 vaccine to more fully protect them against being infected with pneumococcal bacteria.

    Children 1 to 5 years of age should receive a single, supplemental dose of PCV13. It does not matter whether a child received fewer than four or all four doses of PCV7 according to schedule. Children ages 1 to 6 with conditions that compromise their immune systems — such as sickle cell disease or HIV infection — should receive a single dose of PCV13 too.

    This single supplemental dose is just as safe as the older vaccine and receiving it poses no new dangers. Indeed, it will help protect these children against the additional six strains of pneumococcal bacteria.

    Back to top

    CDC sites:

    PCV13 (Pneumococcal Conjugate) Vaccine for Providers

    Licensure of a 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Recommendations for Use Among Children
    • Website Feedback
    • Site Map

    © 2012 Palo Alto Medical Foundation. All rights reserved. Sutter Health is a registered trademark of Sutter Health®, Reg. U.S. Patent. & Trademark office.
    Serving communities around Palo Alto, Mountain View, Fremont, San Jose, San Francisco, Oakland, Dublin, San Mateo & Santa Cruz.